Key Advantages

The Algernon Value Proposition

  • Advancing new drug treatments for billion dollar global disease markets.

     

  • Advancing 4 lead compounds that either out performed or matched the gold standard of care treatment or one the leading drugs under development, in repeated animal in vivo studies. See our Pipeline

     

  • Re-purposed compounds have a much lower risk of failing in human trials as a result of safety issues.

     

  • In the planning stages for 4 separate phase II clinical trials.

     

  • Highly capital efficient business model.

     

  • Experienced management team & globally recognized medical advisory board.